Morgan Stanley raises target for Synopsys stock to USD 574

Published on 10/26/2026 at 17:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal third-quarter revenue rose 42.40 percent. Synopsys stock costs EUR 407.25 on October 26, 2026, minus 0.31 percent versus the Xetra close.

Analyst target and reporting date

Morgan Stanley raised its Synopsys target to USD 574 from USD 500 on October 20, 2026.
Fiscal third-quarter revenue rose 42.40 percent to USD 2.48 billion for the period ended July 31, 2026.
Synopsys stock costs EUR 407.25 at Lang & Schwarz on October 26, 2026 at 5:49 p.m. CEST, 0.31 percent below the EUR 408.50 Xetra close.
The stock's price-to-earnings ratio was 79.73, with a USD 87.5 billion market capitalization on October 26, 2026.

Synopsys Inc., US8716071076, Illustration mit AI erstellt.

Morgan Stanley raised its Synopsys price target to USD 574 from USD 500 on October 20, 2026, according to Markets Insider. The change keeps the analyst firm's Overweight rating in place. At Lang & Schwarz, Synopsys stock was trading at EUR 407.25 on October 26, 2026 at 5:49 p.m. CEST, 0.31 percent below the Xetra close of October 26, 2026 at EUR 408.50.

Revenue reached USD 2.48 billion

Synopsys reported fiscal third-quarter revenue of USD 2.477 billion for the period ended July 31, 2026, up 42.40 percent from USD 1.740 billion a year earlier. Barchart reported that net income attributable to Synopsys rose to USD 545.8 million from USD 242.5 million in the year-ago quarter. Non-GAAP earnings per share increased to USD 3.91 from USD 3.39.

Stock stays below its yearly high

The euro quotation's 52-week range was EUR 318.00 to EUR 464.50 on October 26, 2026. At EUR 407.25, Synopsys stood 12.33 percent below that high. The primary Nasdaq quotation was USD 456.39 at 12:52 p.m. EDT on October 26, 2026, while the 52-week range in that market was USD 362.55 to USD 539.48.

Valuation and company dates

Morgan Stanley's USD 574 target was 25.77 percent above the USD 456.39 Nasdaq quotation on October 26, 2026. Synopsys carried a price-to-earnings ratio of 79.73 and a USD 87.5 billion market capitalization at the same date.

Synopsys listed its fiscal third-quarter results on August 26, 2026, and its 2026 Investor Day on September 30, 2026. Those dates frame the latest operating and strategic information used by analysts, while the current quotation remains below the euro year's high.

What the target means for valuation

The target revision puts the analyst's USD 574 view 25.77 percent above the Nasdaq price cited on October 26, 2026. That gap is material beside the company's 79.73 price-to-earnings ratio, so the stock's valuation remains central to how investors read the growth figures. The reported third-quarter revenue increase also includes the contribution from Ansys, which Synopsys acquired in July 2025, according to Barchart.

Synopsys market facts

The combination of a USD 574 analyst target, 42.40 percent fiscal third-quarter revenue growth and a 12.33 percent distance from the euro 52-week high gives investors three measurable reference points. The current euro quotation is slightly below the Xetra close, even as the longer-term earnings comparison remains stronger than the daily move.

The further course of trading is shown by the continuously updated real-time quote of Synopsys stock.